阿里大文娛發布「港藝振興計劃」 未來五年在四大領域投入最少50億元
阿里大文娛發布「港藝振興計劃」,擬於未來五年在香港劇集、電影、演出和青年人才培養四大領域,投入不低於50億港元。
阿里大文娛董事長兼CEO樊路遠表示,希望與香港文化娛樂界展開深度合作。阿里影業(01060.HK)還發布了多部港片,並宣布將在香港打造第二總部。
文化體育及旅遊局局長楊潤雄今早(11日)在發布會上表示,過去多年阿里大文娛與香港的合作一直十分密切,公司參與投資、發行或參與製作大量的影視作品,不斷創出好成績,例如電影《毒舌大狀》和電視劇《新聞女王》等。很高興看到阿里大文娛提出「港藝振興計劃」,阿里影業將香港作為第二個總部,正式成為香港影視娛樂業的一分子。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.